This observation suggested that PBRM1 deficiency is closely associated with anti-PD1 immunotherapeutic sensitivity in colorectal cancer and may correlate with T-cell infiltration in the tumor mesenchyme (Figure 1G). This evidence concerns the gene PBRM1 and colorectal cancer.